← SynDRA
EPRISTERIDE
SynDRA canonical compound SYN0004700 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | SRD5A1 | SRD5A2 |
|---|
| Mechanism of action | 5 alpha reductase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- 5 alpha reductase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Drug classes
- 5-alpha Reductase Inhibitors
Cross-references
Synonyms
- Epristerida
- ONO-9302
- ONO9302
- SK&F-105657
- Zariflo
- SKB-105657
- SKF-105657
- ONO 9302
- SKF 105657
- DTXCID2028569
- epristeridum
- RefChem:921066
- Epristeride [USAN:INN:BAN]
- CCRIS 8535
- UNII-39517A04PS
- ONO-9302;SKF105657
- NCGC00182849-01
- Epristeride (Standard)
- EPRISTERIDE [MI]
- EPRISTERIDE [INN]
- EPRISTERIDE [JAN]
- EPRISTERIDE [USAN]
- SCHEMBL61222
- EPRISTERIDE [WHO-DD]
- skf105657
- Epristeride (JAN/USAN/INN)
- orb1707330
- CHEBI:31552
- VAPSMQAHNAZRKC-PQWRYPMOSA-N
- Tox21_112993
- BDBM50031890
- BDBM50043604
- AKOS030573838
- CS-7978
- EBC-610058
- HY-107385R
- DA-52959
- MS-26777
- HY-107385
Look up EPRISTERIDE in the interactive SynDRA portal →